ClinicalTrials.Veeva

Menu

Assessing the Feasibility of the Patient-Reported Outcomes Based Model for Community Care of Patients With Axial Spondyloarthritis Via a Type 1 Pilot Hybrid Effectiveness-Implementation Trial Using the RE-AIM Framework (PROMise-Pilot)

S

Singapore Health Services (SingHealth)

Status

Not yet enrolling

Conditions

Axial Spondyloarthritis

Treatments

Procedure: PROMise Model of Care

Study type

Interventional

Funder types

Other

Identifiers

NCT06968247
2024-4044
AM/HRT048/2025 (SRDUKAMR25H8) (Other Grant/Funding Number)

Details and patient eligibility

About

The goal of this clinical trial is to facilitate the implementation of PROMs-based care for patients with axial spondyloarthritis.

The main questions it aims to answer are:

  • What are the barriers, facilitators and strategies to implement PROMs-based care?
  • Can the PROMise algorithm successfully review and postpone appointments of eligible patients?
  • How feasible is PROMs-based care in patients with axial spondyloarthritis?

Researchers will implement PROMs-Based care and see if PROMs-Based care is feasible and understand patient's opinions on PROMs-Based care implemented.

Participants will:

  • Be randomized to either receive intervention (PROM-based care) or control (usual care). Randomisation means assigning you to one of two groups by chance, like tossing a coin or rolling dice.
  • That receive PROMs-based care, will be sent PROMs questionnaires that ask them about their health conditions via SMS at a regular interval of 4 months.
  • Have their appointments postponed by 4 months, if the PROMise algorithm with specific thresholds (with overview from the rheumatology care team) assess their condition as stable through their blood test results and PROMs questionnaire.
  • Have a cap of 12 months between physician visits.

Enrollment

70 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with axial spondyloarthritis according to the 2009 ASAS Classification Criteria of AxSpA
  • has been receiving care in Singapore General Hospital for at least 6 months
  • aged 21 years and above

Exclusion criteria

  • Bath Ankylosing Spondylitis Disease Activity Index score of >4

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

PROMise Model of Care
Experimental group
Description:
Patients will go for blood tests and be sent PROMs questionnaire prior to planned clinic appointments. The results of the blood tests and questionnaire will be reviewed by a physician. The physician will postpone patient's appointment if the patient is assessed as stable. Any physician-endorsed medication will be sent via a medication delivery service.
Treatment:
Procedure: PROMise Model of Care
Control
No Intervention group
Description:
Usual care

Trial contacts and locations

1

Loading...

Central trial contact

Xin Ru Chew, BSc(Science)(Hons); Yu Heng Kwan, BSc(Pharm)(Hons), MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems